ICG
BIO icon

InterOcean Capital Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

InterOcean Capital Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-699
Closed -$265K – 460
2023
Q2 		$265K Sell
699
-468
-40% -$190K 0.01% 374
2023
Q1 		$559K Sell
1,167
-36
-3% -$16.9K 0.02% 247
2022
Q4 		$506K Buy
1,203
+182
+18% +$73.5K 0.02% 259
2022
Q3 		$426K Buy
1,021
+363
+55% +$181K 0.02% 260
2022
Q2 		$326K Buy
+658
New +$343K 0.01% 315

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

InterOcean Capital Group's BIO Position: Q3 2023 in Review

InterOcean Capital Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 699 shares — an estimated $265K sold.

InterOcean Capital Group first reported a position in BIO in Q2 2022 and held it in 5 quarters. The position peaked at $559K in Q1 2023. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • InterOcean Capital Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • InterOcean Capital Group sold 699 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $265K.
  • InterOcean Capital Group first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 5 quarters.
  • InterOcean Capital Group's Bio-Rad Laboratories Class A position peaked at $559K in Q1 2023.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on InterOcean Capital Group's 13F filing for Q3 2023, filed 14 Nov 2023.